These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2311673)

  • 1. Reproducible vasodilatation by platelet-activating factor in blood- and Krebs-perfused rat kidneys is albumin-dependent.
    Gerkens JF
    Eur J Pharmacol; 1990 Feb; 177(3):119-26. PubMed ID: 2311673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney.
    Schwertschlag U; Scherf H; Gerber JG; Mathias M; Nies AS
    Circ Res; 1987 Apr; 60(4):534-9. PubMed ID: 3297384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vasoconstriction by platelet activating factor in the in situ blood perfused rat mesentery.
    Gerkens JF
    Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):161-7. PubMed ID: 2721028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP; Nourshargh S; Hellewell PG; Williams TJ
    Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vascular response to platelet-activating factor in the perfused rat heart.
    Man RY; Hu W; Kinnaird AA
    J Lipid Mediat; 1990; 2(2):75-83. PubMed ID: 2135670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented potentiation of renal vasoconstrictor responses by thromboxane A2 receptor stimulation in the alloxan-diabetic rat.
    Hodgson WC; King RG; Boura AL
    J Pharm Pharmacol; 1990 Jun; 42(6):423-7. PubMed ID: 1979623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar coronary vascular effects in the rat perfused heart of platelet-activating factor structural analogues with agonist and antagonist properties.
    Man RY; Kinnaird AA
    Br J Pharmacol; 1995 Nov; 116(5):2359-64. PubMed ID: 8581269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barbiturate inhibition of endothelium-dependent dilatation of blood- and Krebs-perfused rat tail arteries.
    Gerkens JF
    Eur J Pharmacol; 1987 Feb; 134(3):293-301. PubMed ID: 3569416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PAF on isolated rat airways perfused with blood-free solution.
    Munoz NM; Kirchhoff CF; Strek ME; Blumenthal RN; Leff AR
    Am J Physiol; 1991 Apr; 260(4 Pt 1):L260-7. PubMed ID: 2018147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.
    Handa RK; Strandhoy JW; Buckalew VM
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F108-16. PubMed ID: 1907104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.
    Hu WM; Choy PC; Man RY
    Lipids; 1991 Sep; 26(9):700-4. PubMed ID: 1762514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-dependent vasodilator effects of platelet activating factor on rat resistance vessels.
    Kamata K; Mori T; Shigenobu K; Kasuya Y
    Br J Pharmacol; 1989 Dec; 98(4):1360-4. PubMed ID: 2611496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
    Rump LC; Schollmeyer P
    Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor is a renal vasodilator in the anesthetized rat.
    Handa RK; Strandhoy JW; Buckalew VM
    Am J Physiol; 1990 Jun; 258(6 Pt 2):F1504-9. PubMed ID: 2360650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney.
    Cailleaux S; Lopes-Martins RA; Aimbire F; Cordeiro RS; Tibiriçá E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):505-11. PubMed ID: 10431763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats.
    Perico N; Remuzzi A; Dadan J; Battaglia C; Remuzzi G
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F85-90. PubMed ID: 1713421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of platelet activating factor by the isolated kidney is not linked to the production of prostaglandins.
    Nies AS; Tunney A; Barden A; Sturm M; Vandongen R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):590-4. PubMed ID: 1941608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.